Drug or chemical induced diabetes mellitus with other diabetic kidney complication
ICD-10 E09.29 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with other diabetic kidney complication.
E09.29 refers to diabetes mellitus that is induced by drugs or chemicals, specifically highlighting cases where the patient also experiences other complications related to diabetic kidney disease. This condition can arise from various medications, including glucocorticoids, antipsychotics, and certain chemotherapy agents, which can lead to insulin resistance or impaired insulin secretion. Patients may present with elevated blood glucose levels and may require careful monitoring of HbA1c levels to assess long-term glycemic control. The presence of diabetic kidney complications, such as diabetic nephropathy, necessitates a comprehensive management approach, including potential adjustments in medication, dietary modifications, and regular monitoring of renal function. Insulin management may be required, especially if the patient exhibits significant hyperglycemia. The complexity of managing drug-induced diabetes lies in the need to balance the treatment of the underlying condition for which the drug was prescribed while addressing the metabolic disturbances caused by the drug itself.
Thorough documentation of diabetes management, including medication history and HbA1c levels.
Patients presenting with new-onset diabetes after starting corticosteroids or antipsychotics.
Endocrinologists must ensure that the cause of diabetes is clearly documented to support the use of E09.29.
Detailed records of renal function tests and any diabetic nephropathy assessments.
Patients with diabetes and chronic kidney disease requiring renal protective strategies.
Nephrologists should document the relationship between diabetes management and kidney function closely.
Used for follow-up visits for diabetes management and monitoring of kidney function.
Document patient history, medication changes, and lab results.
Endocrinologists should focus on diabetes management, while nephrologists should emphasize renal function.
Common drugs include glucocorticoids, certain antipsychotics, and some medications used in cancer treatment, which can lead to insulin resistance or impaired insulin secretion.
